StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Selling, General & Administrative by Quarter

Selling, General & Administrative ($M)

QuarterlyAnnual

Novartis Selling, General & Administrative: $3,082M in Q3 2026, down 6.8% from a year earlier.

Latest, Q3 2026
3,082
Period ended Sep 30, 2026
Change on a year earlier
-6.8%
3,308 in Q3 2025
History
36 quarters
Since Q2 2017
Sources
31
Documents cited below

Where the Q3 2026 figure comes from

“|| Selling, general and administration | – 3 082 | – 3 308”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Postgres DB + Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSelling, General & Administrative ($M)Year on yearSource
Q3 2026Sep 30, 20263,082-6.8%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20263,241-5.8%Novartis 6-K (0001114448-26-000012, filed 2026-07-21) ↗
Q1 2026Mar 31, 20263,140+2.7%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20253,440-1.7%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20253,308+5.6%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 20253,442+11.4%Novartis 6-K (0001370368-25-000012, filed 2025-07-17) ↗
Q1 2025Mar 31, 20253,058+7.7%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 20243,501+1.7%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 20243,134+1.4%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 20243,0910.0%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q1 2024Mar 31, 20242,840-1.8%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 20233,444+8.2%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 20233,091+5.3%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 20233,091-13.7%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q1 2023Mar 31, 20232,891-17.7%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 20223,183-20.1%Novartis Form 6-K (0001370368-24-000007) ↗

Cite this data

StockData. (2026). Novartis Selling, General & Administrative ($M), quarterly Q2 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-is-sga

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.